Evidence map›Paper›PMID 40316347›Full record

ArticleBMJ open2025

Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional study.

Arian Omeranovic, Julie Lapointe, Philippe Fortier, Anne-Sophie Bergeron, Michel Dorval, Jocelyne Chiquette, Asma Boubaker, Laurence Eloy, Annie Turgeon, Laurence Lambert-Côté and 11 more

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Arian OmeranovicOncology Division, CHU de Québec-Université Laval Research Center, Hopital du Saint-Sacrement, Québec, Québec, Canada.
Julie LapointeOncology Division, CHU de Québec-Université Laval Research Center, Hopital du Saint-Sacrement, Québec, Québec, Canada.
Philippe FortierOncology Division, CHU de Québec-Université Laval Research Center, Hopital du Saint-Sacrement, Québec, Québec, Canada.ORCID http://orcid.org/0009-0001-0060-511X
Anne-Sophie BergeronDépartement des Sciences Infirmières, Université du Québec à Rimouski-Campus de Lévis, Lévis, Québec, Canada.
Michel DorvalOncology Division, CHU de Québec-Université Laval Research Center, Hopital du Saint-Sacrement, Québec, Québec, Canada.
Jocelyne ChiquetteOncology Division, CHU de Québec-Université Laval Research Center, Hopital du Saint-Sacrement, Québec, Québec, Canada.
Asma BoubakerOncology Division, CHU de Québec-Université Laval Research Center, Hopital du Saint-Sacrement, Québec, Québec, Canada.
Laurence EloyProgramme québécois de cancérologie, Ministère de la Santé et des Services Sociaux du Québec, Québec, Québec, Canada.
Annie TurgeonOncology Division, CHU de Québec-Université Laval Research Center, Hopital du Saint-Sacrement, Québec, Québec, Canada.
Laurence Lambert-CôtéOncology Division, CHU de Québec-Université Laval Research Center, Hopital du Saint-Sacrement, Québec, Québec, Canada.
Yann JolyCenter of Genomics and Policy, McGill University, Montreal, Québec, Canada.ORCID http://orcid.org/0000-0002-8775-2322
Jennifer D BrooksUniversity of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.
Meghan J WalkerUniversity of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.
Tracy StockleyLaboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Nora PashayanDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Antonis AntoniouDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Douglas EastonDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Anna Maria ChiarelliUniversity of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.
Bartha KnoppersCenter of Genomics and Policy, McGill University, Montreal, Québec, Canada.
Jacques SimardOncology Division, CHU de Québec-Université Laval Research Center, Hopital du Saint-Sacrement, Québec, Québec, Canada.
Hermann NabiOncology Division, CHU de Québec-Université Laval Research Center, Hopital du Saint-Sacrement, Québec, Québec, Canada Hermann.Nabi@crchudequebec.ulaval.ca.ORCID http://orcid.org/0000-0002-7832-0413

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe primary care providers' (PCPs) experience and satisfaction with receiving risk communication documents on their patient's breast cancer (BC) risk assessment and proposed screening action plan.

designDescriptive cross-sectional study.

settingA survey was distributed to all 763 PCPs linked to 1642 women participating in the Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I) research project in Quebec, approximately 1-4 months after the delivery of the risk communication documents. The recruitment phase took place from July 2021 to July 2022.

participantsPCPs.

main outcome measuresDescriptive analyses were conducted to report participants' experiences and satisfaction with receiving risk communication. Responses to two open-ended questions were subjected to content analysis.

resultsA total of 168 PCPs answered the survey, from which 73% reported being women and 74% having more than 15 years of practice. Only 38% were familiar with the risk-based BC screening approach prior to receiving their patient risk category. A majority (86%) agreed with the screening approach and would recommend it to their patients if implemented at the population level. A majority of PCPs also reported understanding the information provided (92%) and expressed agreement with the proposed BC screening action plan (89%). Some PCPs recommended simplifying the materials, acknowledging the potential increase in workload and emphasising the need for careful planning of professional training efforts.

conclusionPCPs expressed positive attitudes towards a risk-based BC screening approach and were generally satisfied with the information provided. This study suggests that, if introduced in Canada in a manner similar to the PERSPECTIVE I&I project, risk-based BC screening would likely be supported by most PCPs. However, they emphasised the importance of addressing concerns such as professional training and the potential impact on workload if the approach were to be implemented at the population level. Future qualitative studies are needed to further explore the training needs of PCPs and to develop strategies for integrating this approach with the high workloads faced by PCPs.

Indexed as

Attitude of Health PersonnelBreast NeoplasmsEarly Detection of CancerPhysicians, Primary CarePrimary Health CareAdultAgedCommunicationCross-Sectional StudiesFemaleHumansMaleMiddle AgedQuebecRisk AssessmentSurveys and QuestionnairesBreast tumoursCancer geneticsEpidemiologyPUBLIC HEALTH

Identifiers

PMID40316347
PMCPMC12049900

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.